From Early Pioneers to Recent Brain Network Findings
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Histamine in Psychiatry: Promethazine As a Sedative Anticholinergic
BJPsych Advances (2019), vol. 25, 265–268 doi: 10.1192/bja.2019.21 CLINICAL Histamine in psychiatry: REFLECTION promethazine as a sedative anticholinergic John Cookson (strongly influenced by the ideas of Claude Bernard John Cookson, FRCPsych, FRCP, is SUMMARY and Louis Pasteur). There he met Filomena Nitti, a consultant in general adult psych- iatry for the Royal London Hospital The author reflects on discoveries over the course daughter of a former prime minister of Italy. They of a century concerning histamine as a potent and East London NHS Foundation married in 1938 and she became her husband’slife- chemical signal and neurotransmitter, the develop- Trust. He trained in physiology and long co-worker. They moved in 1947 to the pharmacology at the University of ment of antihistamines, including promethazine, Institute of Health in Rome. In 1957 he was Oxford and he has a career-long and chlorpromazine from a common precursor, interest in psychopharmacology. His and the recognition of a major brain pathway awarded a Nobel Prize for his work in developing duties have included work in psychi- involving histamine. Although chlorpromazine has drugs ‘blocking the effects of certain substances atric intensive care units since 1988. been succeeded by numerous other antipsycho- occurring in the body, especially in its blood vessels He has co-authored two editions of tics, promethazine remains the antihistamine and skeletal muscles’ (Oliverio 1994). He and his Use of Drugs in Psychiatry, published recommended for sedation in acutely disturbed by Gaskell. research student Marianne Staub introduced the Correspondence: Dr John Cookson, patients, largely because it is potently anticholiner- first antihistamine in 1937, developed by altering Tower Hamlets Centre for Mental gic at atropinic muscarinic receptors and therefore the structures of drugs found to block known trans- Health, Mile End Hospital, Bancroft anti-Parkinsonian: this means it is also useful in mitters – acetylcholine and adrenaline – such as atro- Road, London E1 4DG, UK. -
Cortical and Subcortical Neuroanatomical Signatures of Schizotypy in 3,004 Individuals Assessed in a Worldwide ENIGMA Study
medRxiv preprint doi: https://doi.org/10.1101/2021.04.29.21255609; this version posted April 30, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Cortical and Subcortical Neuroanatomical Signatures of Schizotypy in 3,004 Individuals Assessed in a Worldwide ENIGMA Study Matthias Kirschner, MD1,2*; Benazir Hodzic-Santor, BA1*; Mathilde Antoniades, PhD3; Igor Nenadic, MD4; Tilo Kircher, MD PhD4; Axel Krug, PhD4;29; Tina Meller, PhD4; Dominik Grotegerd, PhD6; Alex Fornito, PhD5; Aurina Arnatkeviciute, PhD5; Mark A Bellgrove, PhD5; Jeggan Tiego, PhD5; Udo Dannlowski, MD PhD6; Katharina Koch, PhD6; Carina Hülsmann, MSc6; Harald Kugel, PhD35; Verena Enneking, MSc6; Melissa Klug, PhD6; Elisabeth J. Leehr, PhD6; Joscha Böhnlein, MSc6; Marius Gruber, MSc6; David Mehler, PhD6; Pamela DeRosse, PhD7,30,31; Ashley Moyett, MSc7; Bernhard T. Baune, MD PhD6,8; Melissa Green, PhD9,32; Yann Quidé, PhD9,32; Christos Pantelis, MD10; Raymond Chan, PhD 11; Yi Wang, PhD11; Ulrich Ettinger, PhD12; Martin Debbané, PhD13; Melodie Derome, PhD13; Christian Gaser, PhD14; Bianca Besteher, MD14; Kelly Diederen, PhD3; Tom J Spencer, PhD3; Paul Fletcher, MD, PhD36; Wulf Rössler, MD15,33,34; Lukasz Smigielski, PhD15; Veena Kumari, PhD16; Preethi Premkumar, PhD16; Haeme R. P. Park, PhD17; Kristina Wiebels, PhD17; Imke Lemmers-Jansen, PhD18; James Gilleen, PhD3,19; Paul Allen, PhD19; Petya Kozhuharova, MSc19; Jan-Bernard Marsman, PhD20; Irina Lebedeva, PhD21; Alexander Tomyshev, MSc21; Anna Mukhorina, PhD21; Stefan Kaiser, MD22; Anne-Kathrin Fett, PhD3,23; Iris Sommer, MD PhD20; Sanne Schuite-Koops, PhD20; Casey Paquola, PhD1; Sara Larivière, MSc1; Boris Bernhardt PhD1; Alain Dagher, MD1; Phillip Grant, PhD24; Theo G. -
Linking Schizophrenia Symptoms, Schizotypy, and Normal Personality
Schizophrenia Bulletin doi:10.1093/schbul/sbz005 Downloaded from https://academic.oup.com/schizophreniabulletin/advance-article-abstract/doi/10.1093/schbul/sbz005/5310427 by [email protected] on 27 August 2019 Common Taxonomy of Traits and Symptoms: Linking Schizophrenia Symptoms, Schizotypy, and Normal Personality David C. Cicero*,1, Katherine G. Jonas2, , Kaiqiao Li2, Greg Perlman2, and Roman Kotov2 1Department of Psychology, University of Hawaii at Manoa, Honolulu, HI; 2Department of Psychiatry, Stony Brook University, Stony Brook, NY *To whom correspondence should be addressed; tel: 808-956-3695, fax: 808-956-4700, e-mail: [email protected] The associations among normal personality and many Introduction mental disorders are well established, but it remains Trait-based paradigms, which have treated psychopa- unclear whether and how symptoms of schizophrenia and thology as fully dimensional, have been useful in under- schizotypal traits align with the personality taxonomy. standing psychopathology, particularly internalizing and This study examined the joint factor structure of nor- externalizing disorders.1–3 The Hierarchical Taxonomy mal personality, schizotypy, and schizophrenia symptoms of Psychopathology (HiTOP) seeks to improve on tra- in people with psychotic disorders (n = 288) and never- ditional diagnostic systems, such as the Diagnostic and psychotic adults (n = 257) in the Suffolk County Mental Statistical Manual of Mental Disorders (DSM) and Health Project. First, we evaluated the structure of International Classification of Diseases (ICD), and con- schizotypal (positive schizotypy, negative schizotypy, and ceptualize psychopathology dimensionally.4 A major mistrust) and normal traits. In both the psychotic-disor- dimension within HiTOP is the psychotic spectrum, der and never-psychotic groups, the best-fitting model had which ranges from normal personality to schizotypal 5 factors: neuroticism, extraversion, conscientiousness, traits to frank psychosis. -
Women Neuropsychiatrists on Wagner-Jauregg's Staff in Vienna at the Time of the Nobel Award: Ordeal and Fortitude
History of Psychiatry Women neuropsychiatrists on Wagner-Jauregg’s staff in Vienna at the time of the Nobel award: ordeal and fortitude Lazaros C Triarhou University of Macedonia, Greece Running Title: Women Neuropsychiatrists in 1927 Vienna Corresponding author: Lazaros C. Triarhou, Laboratory of Theoretical and Applied Neuroscience and Graduate Program in Neuroscience and Education, University of Macedonia, Egnatia 156, Thessalonica 54006, Greece. E-Mail: [email protected] ORCID id: 0000-0001-6544-5738 2 Abstract This article profiles the scientific lives of six women on the staff of the Clinic of Neurology and Psychiatry at the University of Vienna in 1927, the year when its director, Julius Wagner-Jauregg (1857–1940), was awarded the Nobel Prize in Physiology or Medicine. They were all of Jewish descent and had to leave Austria in the 1930s to escape from the National Socialist regime. With a solid background in brain science and mental disorders, Alexandra Adler (1901–2001), Edith Klemperer (1898–1987), Annie Reich (1902–1971), Lydia Sicher (1890– 1962) and Edith Vincze (1900–1940) pursued academic careers in the United States, while Fanny Halpern (1899–1952) spent 18 years in Shanghai, where she laid the foundations of modern Chinese psychiatry, before going to Canada. At the dawn of their medical career, they were among the first women to practice neurology and psychiatry both in Austria and overseas. Keywords Women in psychiatry, Jewish physicians, University of Vienna, Interwar period, Austrian Annexation 3 Introduction There is a historic group photograph of the faculty and staff of the Neurology and Psychiatry Clinic in Vienna, taken on 7 November 1927 (Figure 1). -
The Creative Advantages of Schizophrenia
The Creative Advantages of Schizophrenia The Creative Advantages of Schizophrenia: The Muse and the Mad Hatter By Paul Kiritsis The Creative Advantages of Schizophrenia: The Muse and the Mad Hatter By Paul Kiritsis This book first published 2019 Cambridge Scholars Publishing Lady Stephenson Library, Newcastle upon Tyne, NE6 2PA, UK British Library Cataloguing in Publication Data A catalogue record for this book is available from the British Library Copyright © 2019 by Paul Kiritsis All rights for this book reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the copyright owner. ISBN (10): 1-5275-3165-1 ISBN (13): 978-1-5275-3165-9 For Christos Stamboulakis TABLE OF CONTENTS List of Illustrations ...................................................................................................... ix Acknowledgements ..................................................................................................... xi Foreword........................................................................................................................ xiii Introduction ..................................................................................................................... 1 Chapter One ..................................................................................................................... 7 Schizophrenia as a Social Construct Chapter Two ................................................................................................................. -
Defining Dimensions in Schizotypy: Factor Structure Replication and External Validation of the Schizotypal Personality Questionnaire – Brief Revised Updated (SPQ-BRU)
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Theses, Dissertations, and Student Research: Psychology, Department of Department of Psychology Winter 12-12-2016 Defining Dimensions In Schizotypy: Factor Structure Replication And External Validation Of The chiS zotypal Personality Questionnaire – Brief Revised Updated (SPQ-BRU). Elaina Montague University of Nebraska-Lincoln, [email protected] Follow this and additional works at: http://digitalcommons.unl.edu/psychdiss Part of the Clinical Psychology Commons Montague, Elaina, "Defining Dimensions In Schizotypy: Factor Structure Replication And External Validation Of The chiS zotypal Personality Questionnaire – Brief Revised Updated (SPQ-BRU)." (2016). Theses, Dissertations, and Student Research: Department of Psychology. 90. http://digitalcommons.unl.edu/psychdiss/90 This Article is brought to you for free and open access by the Psychology, Department of at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Theses, Dissertations, and Student Research: Department of Psychology by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. Defining Dimensions in Schizotypy: Factor Structure Replication and External Validation of the Schizotypal Personality Questionnaire – Brief Revised Updated (SPQ-BRU). by Elaina Montague, M.A. A Research Proposal Presented to the Faculty of The Clinical Psychology Training Program In Fulfillment of the Masters-Equivalent Research Project (MERP) Proposal -
On Henry Miller
© Copyright, Princeton University Press. No part of this book may be distributed, posted, or reproduced in any form by digital or mechanical means without prior written permission of the publisher. In Praise of Flight There is no salvation in becoming adapted to a world which is crazy. — Henry Miller, The Colossus of Maroussi La fuite reste souvent, loin des côtes, la seule façon de sauver le bateau et son équipage. Elle permet aussi de découvrir des rivages inconnus qui surgiront à l’horizon des calmes retrouvés. Rivages inconnus qu’ignoreront toujours ceux qui ont la chance apparente de pouvoir suivre la route des cargos et des tankers, la route sans imprévu imposée par les compagnies de trans- port maritime. Vous connaissez sans doute un voilier nommé “Désir.” — Henri Laborit, Éloge de la fuite A man wakes. He knows exactly what is going to happen today, or at least he thinks he does (like everyone, he knows that the unexpected might occur at any time, that he might go to see his doctor and be told he has an inoperable cancer, or his girlfriend, who stood by him all through that messy divorce, will call him at the office mid- morning to say that she has met someone else, but he keeps the thought of random harm • 1 For general queries, contact [email protected] © Copyright, Princeton University Press. No part of this book may be distributed, posted, or reproduced in any form by digital or mechanical means without prior written permission of the publisher. at bay as well as he is able, usually by means of a combination of superstition, moral duplicity, and steady, if uninventive, self- medication). -
The Placement of Hypomania Within a Structural Model Of
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by ScholarSpace at University of Hawai'i at Manoa THE PLACEMENT OF HYPOMANIA WITHIN A STRUCTURAL MODEL OF PSYCHOPATHOLOGY INCLUDING THOUGHT DISORDER AND INTERNALIZING SPECTRA A THESIS SUBMITTED TO THE GRADUATE DIVISION OF THE UNIVERSITY OF HAWAI‘I AT MĀNOA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF ARTS IN PSYCHOLOGY DECEMBER 2017 By Jonathan R. Cohn Thesis Committee: David Cicero, Chairperson Charlene Baker Charles Mueller Keywords: structural psychopathology, schizotypy, hypomania, OCD, thought disorder Table of Contents List of Tables ................................................................................................................................ iii List of Figures ............................................................................................................................... iv Introduction ....................................................................................................................................1 Current Study .....................................................................................................................14 Method ..........................................................................................................................................15 Participants ........................................................................................................................15 Materials ............................................................................................................................15 -
Toxicol Rev 2004; 23 (1): 21-31 GHB SYMPOSIUM 1176-2551/04/0001-0021/$31.00/0
Toxicol Rev 2004; 23 (1): 21-31 GHB SYMPOSIUM 1176-2551/04/0001-0021/$31.00/0 2004 Adis Data Information BV. All rights reserved. γ-Butyrolactone and 1,4-Butanediol Abused Analogues of γ-Hydroxybutyrate Robert B. Palmer1,2 1 Toxicology Associates, Prof LLC, Denver, Colorado, USA 2 Rocky Mountain Poison & Drug Center, Denver, Colorado, USA Contents Abstract ................................................................................................................21 1. Clinical Effects .......................................................................................................23 2. Diagnosis and Management ..........................................................................................25 3. Withdrawal ..........................................................................................................26 4. Conclusion ..........................................................................................................29 Abstract γ-Hydroxybutyrate (GHB) is a GABA-active CNS depressant, commonly used as a drug of abuse. In the early 1990s, the US Drug Enforcement Administration (DEA) warned against the use of GHB and restricted its sale. This diminished availability of GHB caused a shift toward GHB analogues such as γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) as precursors and surrogates. Both GBL and 1,4-BD are metabolically converted to GHB. Furthermore, GBL is commonly used as a starting material for chemical conversion to GHB. As such, the clinical presentation and management of GBL and 1,4-BD -
Well-Being in Schizotypy: the Effect of Subclinical Psychotic Experiences
Psicothema 2018, Vol. 30, No. 2, 177-182 ISSN 0214 - 9915 CODEN PSOTEG Copyright © 2018 Psicothema doi: 10.7334/psicothema2017.100 www.psicothema.com Well-being in schizotypy: The effect of subclinical psychotic experiences Ascensión Fumero1, Rosario J. Marrero1 and Eduardo Fonseca-Pedrero2 1 Universidad de La Laguna and 2 Universidad de La Rioja Abstract Resumen Background: Schizotypy is a multidimensional construct that includes Bienestar en esquizotipia: efecto de las experiencias psicóticas atenuadas. positive, negative, and disorganized dimensions. The healthy schizotypal Antecedentes: la esquizotipia es un constructo multidimensional que model suggests that positive schizotypal features could be associated incluye las dimensiones positiva, negativa y de desorganización cognitiva. with better psychological functioning. The aim of this study was to El modelo de esquizotipia saludable sugiere que los rasgos esquizotípicos analyze whether schizotypal features are associated with subjective and positivos podrían estar asociados con un mejor funcionamiento psychological well-being, and consider whether psychotic-like experiences psicológico. El objetivo de este estudio fue analizar si los rasgos affect well-being. Method: These relationships were investigated in two esquizotípicos se asociaban con el bienestar subjetivo y psicológico, y si hundred non-clinical Spanish adults (mean age = 34.80, S.D. = 14.20). las experiencias psicóticas atenuadas afectaban al bienestar. Método: en Results: Negative schizotypal features were associated with lower well- el estudio participaron 200 adultos españoles (edad media = 34.80, S.D. being, whereas positive schizotypal features were related with greater = 14.20). Resultados: los rasgos esquizotípicos negativos se asociaron well-being. Individuals with subclinical psychotic experiences scored con bajo bienestar y los positivos con mayor bienestar. -
Schizotypy—Do Not Worry, It Is Not All Worrisome
View metadata,Schizophrenia citation and Bulletin similar vol. papers 41 suppl. at core.ac.uk no. 2 pp. S436–S443, 2015 brought to you by CORE doi:10.1093/schbul/sbu185 provided by Serveur académique lausannois Schizotypy—Do Not Worry, It Is Not All Worrisome Christine Mohr*,1 and Gordon Claridge2 1Institute of Psychology, University of Lausanne, Lausanne, Switzerland; 2Department of Experimental Psychology, University of Oxford, Oxford, UK *To whom correspondence should be addressed; Faculté des Sciences Sociales et Politiques, Institut de Psychologie, Bâtiment Geopolis, Quartier Mouline, Bureau Geo – 4117, CH-1015 Lausanne, Switzerland; tel: ++41-21-692-37-53, fax: ++41-21-692-32-65, e-mail: [email protected] A long-standing tradition in personality research in psychol- thus assumed that knowledge acquired from schizotypy ogy, and nowadays increasingly in psychiatry, is that psy- research will also enlighten our knowledge of schizo- chotic and psychotic-like thoughts are considered common phrenia. Within this taxonomic tradition, it is no surprise experiences in the general population. Given their widespread that deficits and similarities with schizophrenia are high- occurrence, such experiences cannot merely reflect patholog- lighted.6 Sticking to a purely pathological perspective, ical functioning. Moreover, reflecting the multi-dimensional- however, seems one-sided when considering that scores ity of schizotypy, some dimensions might be informative for in such self-report questionnaires vary widely in the gen- healthy functioning while others less so. Here, we explored eral population.4,7 Moreover, in longitudinal studies, the these possibilities by reviewing research that links schizotypy large majority of so-called “psychosis-prone” individuals to favorable functioning such as subjective wellbeing, cogni- (high in self-reported schizotypy), will never experience tive functioning (major focus on creativity), and personality a psychiatric illness.4,5 Thus, it is possible that individu- correlates. -
The Neuro Nobels
NEURO NOBELS Richard J. Barohn, MD Gertrude and Dewey Ziegler Professor of Neurology University Distinguished Professor Vice Chancellor for Research President Research Institute Research & Discovery Director, Frontiers: The University of Kansas Clinical and Translational Science Grand Rounds Institute February 14, 2018 1 Alfred Nobel 1833-1896 • Born Stockholm, Sweden • Father involved in machine tools and explosives • Family moved to St. Petersburg when Alfred was young • Father worked on armaments for Russians in the Crimean War… successful business/ naval mines (Also steam engines and eventually oil).. made and lost fortunes • Alfred and brothers educated by private teachers; never attended university or got a degree • Sent to Sweden, Germany, France and USA to study chemical engineering • In Paris met the inventor of nitroglycerin Ascanio Sobrero • 1863- Moved back to Stockholm and worked on nitro but too dangerous.. brother killed in an explosion • To make it safer to use he experimented with different additives and mixed nitro with kieselguhr, turning liquid into paste which could be shaped into rods that could be inserted into drilling holes • 1867- Patented this under name of DYNAMITE • Also invented the blasting cap detonator • These inventions and advances in drilling changed construction • 1875-Invented gelignite, more stable than dynamite and in 1887, ballistics, predecessor of cordite • Overall had over 350 patents 2 Alfred Nobel 1833-1896 The Merchant of Death • Traveled much of his business life, companies throughout Europe and America • Called " Europe's Richest Vagabond" • Solitary man / depressive / never married but had several love relationships • No children • This prompted him to rethink how he would be • Wrote poetry in English, was considered remembered scandalous/blasphemous.